Average Co-Inventor Count = 6.82
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (15 from 1,536 patents)
2. Vanderbilt University (2 from 1,153 patents)
15 patents:
1. RE50594 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
2. 12312363 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
3. 12281099 - Isoindolinone substituted indoles and derivatives as RAS inhibitors
4. 12091399 - Phenyltetrazole derivatives as plasma kallikrein inhibitors
5. 12060367 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
6. 11945812 - Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancer
7. 10919913 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
8. 10882866 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
9. 10717742 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
10. 10695334 - Heteroaromatic carboxamide derivatives as plasma kallikrein inhibitors
11. 10576064 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
12. 10501440 - Heteroarylcarboxamide derivatives as plasma kallikrein inhibitors
13. 10246467 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-p53 inhibitors
14. 10144739 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors
15. 10138251 - Spiro[3H-indole-3,2'-pyrrolidin]-2(1H)-one compounds and derivatives as MDM2-P53 inhibitors